Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sweety, Asija"'
Autor:
Sweety Asija, Abhishek Chatterjee, Jayant S. Goda, Sandhya Yadav, Godhanjali Chekuri, Rahul Purwar
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Glioblastoma is one of the most difficult tumor types to manage, having high morbidity and mortality with available therapies (surgery, radiotherapy and chemotherapy). Immunotherapeutic agents like Oncolytic Viruses (OVs), Immune Checkpoint Inhibitor
Externí odkaz:
https://doaj.org/article/54a77fe295b74b7db7042e7f6852d5d1
Autor:
Aalia N. Khan, Ambalika Chowdhury, Atharva Karulkar, Ankesh Kumar Jaiswal, Ankit Banik, Sweety Asija, Rahul Purwar
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chimeric antigen receptor T cell (CAR-T) therapy demonstrated remarkable success in long-term remission of cancers and other autoimmune diseases. Currently, six products (Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, and Carvykti) are approved by th
Externí odkaz:
https://doaj.org/article/af5e49421f6d4931b359b514d32ae9aa
Autor:
Sweety, Asija, Abhishek, Chatterjee, Sandhya, Yadav, Godhanjali, Chekuri, Atharva, Karulkar, Ankesh Kumar, Jaiswal, Jayant S, Goda, Rahul, Purwar
Publikováno v:
International Reviews of Immunology. 41:582-605
The aggressive and recurrent nature of glioblastoma is multifactorial and has been attributed to its biological heterogeneity, dysfunctional metabolic signaling pathways, rigid blood-brain barrier, inherent resistance to standard therapy due to the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ab1899878e55aaf950a7227194da95
https://doi.org/10.1080/08830185.2022.2101647
https://doi.org/10.1080/08830185.2022.2101647
Autor:
Hasmukh Jain, Atharva Karulkar, Neha Sharma, Manju Sengar, Ankesh Jaiswal, Shreshtha Shah, Aalia Khan, Afrin Firfiray, Sweety Asija, Prashant Suvasia, Priyanshi Suvasia, Juber Pendhari, Devanshi Kalra, Smrithi Ravikumar, Gaurav Narula, Shripad Banavali, Minal Poojary, Sumathi Hiregoudar, Lingaraj Nayak, Bhausaheb Bagal, Prashant R. Tembhare, Sridhar Epari, Navin Khattry, Nikhil Patkar, Sumeet Gujral, Tanuja Shet, Papagudi Ganesan Subramanian, Jayashree Thorat, Sachin Punatar, Anant Gokarn, Kinjalka Ghosh, Archi Agarwal, Preeti Desai, Shashank Ojha, Subhash Yadav, Shil Pushp Bhosale, Sunil Rajadhyaksha, Anisha Navkudkar, Siddharth Laskar, Sumeet Prakash Mirgh, Albeena Nisar, Deepali Pandit, Ruchira Patil, Rahul Purwar, Sattva S. Neelapu, Nirali N. Shah
Publikováno v:
Blood. 140:10332-10334
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ccca2936ab6f4f95d36880f449154b9
https://doi.org/10.1182/blood-2022-166082
https://doi.org/10.1182/blood-2022-166082
Publikováno v:
International reviews of immunology. 41(6)
The unprecedented clinical success of Chimeric Antigen Receptor (CAR) T cell therapy in hematological malignancies has led researchers to study its role in solid tumors. Although, its utility in solid tumors especially in neuroblastoma has begun to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51e237af1486591a56c71e520c63024f
https://pubmed.ncbi.nlm.nih.gov/36191126
https://pubmed.ncbi.nlm.nih.gov/36191126
Autor:
Atharva Karulkar, Hasmukh Jain, Shreshtha Shah, Aalia Khan, Ankesh Jaiswal, Afrin Firfiray, Prashant Suvasia, Priyanshi Suvasia, Juber Pendhari, Sweety Asija, Ambalika Chowdury, Ankit Banik, Smrithi Ravikumar, Neha Sharma, Minal Poojary, Sumathi Hiregoudar, Preeti Desai, Anisha Navkudkar, Sunil Rajadhyaksha, Jayashree Thorat, Prashant R. Tembhare, Albeena Nisar, Manju Sengar, David F. Stroncek, Steven Highfill, Nirali N. Shah, Gaurav Narula, Rahul Purwar
Publikováno v:
Blood. 140:4610-4611
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::784a2db33840bf907e14324f68a93d6d
https://doi.org/10.1182/blood-2022-168928
https://doi.org/10.1182/blood-2022-168928
Autor:
Sushant Kumar, Alka Dwivedi, Nirali N. Shah, Atharva Karulkar, Rahul Purwar, David F. Stroncek, Minal Poojary, Sweety Asija, Terry J. Fry, Deepali Patil, S. Srinivasan, Atish Kizhakeyil, Steven L. Highfill, Hasmukh Jain, Albeena Nisar, Gaurav Narula, Bajarang Vasant Kumbhar, Afrin Rafiq, Ankesh Kumar Jaiswal, Shripad Banavali, Sarbari Ghosh
Publikováno v:
Molecular cancer therapeutics. 20(5)
Recent studies have described the remarkable clinical outcome of anti-CD19 chimeric antigen receptor (CAR) T cells in treating B-cell malignancies. However, over 50% of patients develop life-threatening toxicities associated with cytokine release syn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5bbd169a5c32c0e7cda951510754239
https://pubmed.ncbi.nlm.nih.gov/33632869
https://pubmed.ncbi.nlm.nih.gov/33632869